EN DE
Watch Mastrad for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Mastrad (ALMAS) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Mastrad stock €0.00, price €0.00, that is 0.6% below the price, quality 16 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive FR · ISIN FR0004155687

M Mastrad logo Thin data Nov 10, 2026

Mastrad

ALMAS · PA
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Fair value €0.0036 · Fairly valued
Revenue last quarter 10% below a year ago.
Quality 16/100
Weak Growth (revenue 5y −37.3 %/yr in EUR)
High debt
Negative free cash flow
Trails peers (2/6)
Narrow moat 41/100 · thin data
Thin data
Estimate⚠ Thinly traded
Watch Mastrad for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€0.7320 €0.0016 Fair Value €0.0036 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range €0.0016 – €0.7320 · fair‑value band €0.0036 – €0.0036 · the €0.0036 price screens above the €0.0036 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Mastrad in your weekly email

Every Wednesday you see whether Mastrad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Mastrad designs, distributes, and sells cooking accessories in France and the Americas. The company offers cooking thermometers under the ORKA brand; and maryse spatulas, pastry molds, whippers, and minute cookers. Mastrad was incorporated in 1994 and is headquartered in Paris, France.

Stock analysis

Mastrad (ALMAS) currently trades at €0.0036, while our estimate is €0.0036, so the stock looks roughly fairly valued today (gap 0.6%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: €0.0036 (bear) to €0.0036 (bull), the price of €0.0036 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 16/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Mastrad reported revenue of €489K in FY2025 versus €9.5M in FY2021, a compound −52.4%/yr. Reported net income was −€1.6M in FY2025.

Key figures

Market cap €815K Micro · P/S ratio 1.09 · EPS (TTM) €−0.0200 · Return on equity −678% · Return on assets (EBIT) −21.0% (5-year average) · Operating margin −336% · Revenue (TTM) €745K · Revenue growth (YoY) −10.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (low confidence).

What moves the price

The share trades about 71% below its 52-week high and 125% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −30% fair-value upside, at −1%, ALMAS screens cheaper than that median.

Fair Value

Bear €0.0036 Fair Value €0.0036 Bull €0.0036
Price €0.0036 · Downside -0.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 16/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 0
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 5
Debt, balance sheet and risk of trouble
Investment 74
Does it invest with discipline instead of growing at any price?
Low Volatility 39
How calm the share price moves, does not count
Price momentum 33
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 9
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−73.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−58.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−37.3%
Start year 2020 (pandemic). Over 10 years: −31.2% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−25.1% (2020) → −334.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch ALMAS, get fair value alerts →

Compare Mastrad with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 239 stocks

Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 16 · Bottom 25%
Fair Value upside −0.6% · Above median
Profitability
Return on assets −45.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −10.2% · Bottom 25%
Balance sheet
Debt / equity 1.99× · Highest 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B 1.40× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 1.09× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)33 · sector 32
FUTURE (revenue growth)0 · sector 20
PAST (return on equity)0 · sector 29
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 53

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Godrej Consumer Products Limited GODREJCP ₹850.65 ₹1,146 +35% vs ALMAS
Puig Brands, S.A PUIG €19.95 €24.28 +22% vs ALMAS
Henkel AG HEN €78.20 €82.55 +6% vs ALMAS
Beiersdorf Aktiengesellschaft, BEI €85.34 €69.09 −19% vs ALMAS
The Clorox Company CLX $106.60 $74.29 −30% vs ALMAS
Church & Dwight Co CHD $111.76 $65.04 −42% vs ALMAS
Colgate-Palmolive Company CL $98.09 $56.16 −43% vs ALMAS
Marico Limited MARICO ₹902.00 ₹493.84 −45% vs ALMAS
The Estée Lauder Companies Inc EL $113.43 $44.21 −61% vs ALMAS
Hindustan Unilever Limited HINDUNILVR ₹1,990 ₹775.25 −61% vs ALMAS

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Mastrad: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Mastrad Fair Value". https://www.fairvalue-calculator.com/stock/ALMAS

Frequently asked questions

Is Mastrad (ALMAS) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is €0.0036 versus a price of €0.0036, about 1% lower (fairly valued).
What is the fair value of ALMAS?
Our estimate for Mastrad is €0.0036 (as of Nov 10, 2026), built from audited fundamentals. The current price: €0.0036.
What is the quality score of ALMAS?
Mastrad has a Quality Score of 16/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mastrad (ALMAS)?
Our calculated price target is the estimate of €0.0036 (as of Nov 10, 2026). Cautious scenario €0.0036, optimistic scenario €0.0036. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Mastrad stock forecast for 2026?
Our estimate puts fair value at €0.0036, about 1% lower versus a price of €0.0036 (fairly valued). Cautious scenario €0.0036, optimistic scenario €0.0036. The calculation is refreshed regularly with new filings.
What is the revenue of Mastrad (ALMAS)?
Mastrad reported trailing-twelve-month revenue of about €745K (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Mastrad (ALMAS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mastrad it is €0.0036 per share (as of Nov 10, 2026), against a price of €0.0036.
Is Mastrad stock overvalued or undervalued in 2026?
As of Nov 10, 2026, ALMAS trades above its calculated fair value: price €0.0036, fair value €0.0036, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALMAS?
No. The price is what the market pays today (€0.0036); the fair value is what the company's own numbers justify (€0.0036). For Mastrad the two are €0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mastrad worth?
The market values Mastrad at about €815K (market capitalisation, as of Nov 10, 2026). Per share that is €0.0036; our models calculate a fair value of €0.0036 per share.
What do the bullish and bearish scenarios say about ALMAS?
Our models span a range for Mastrad: cautious scenario €0.0036, base €0.0036, optimistic €0.0036 per share (as of Nov 10, 2026, price €0.0036). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Mastrad (ALMAS)?
Balance-sheet figures for Mastrad (as of Nov 10, 2026): debt of 1.99 per unit of equity. They feed the Quality Score of 16/100, which measures business quality independently of the share price.
How far is ALMAS from its 52-week high?
Mastrad trades at €0.0036, about 71% below its 52-week high of €0.0124 and 125% above the low of €0.0016 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of €0.0036 is for.
Which stocks are comparable to Mastrad?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mastrad stock attractive at the current price?
The data as of Nov 10, 2026: price €0.0036, calculated fair value €0.0036 (−1%), Quality Score 16/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Mastrad itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mastrad (ALMAS)?
The closing price on Nov 10, 2026 was €0.0036. Our estimate is €0.0036, about 1% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mastrad right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band (€0.0036 to €0.0036), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Mastrad

How large is the market capitalisation of Mastrad (ALMAS)?
The market capitalisation of Mastrad is €815K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mastrad (ALMAS)?
The price-to-sales ratio of Mastrad is 1.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mastrad (ALMAS)?
Earnings per share at Mastrad are €−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Mastrad (ALMAS)?
The return on equity (ROE) of Mastrad is −678% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mastrad (ALMAS)?
On an EBIT basis the return on assets of Mastrad is −21.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mastrad (ALMAS)?
The operating margin of Mastrad is −336% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mastrad (ALMAS)?
Revenue at Mastrad is growing −10.2% versus a year earlier (3y avg −58.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Mastrad (ALMAS) generate?
The free cash flow of Mastrad is −€73.0K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Mastrad (ALMAS) carry?
The net debt of Mastrad is €1.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Mastrad in the live analysis

One click puts Mastrad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.